Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease. Ostrominski JW, Hojbjerg Lassen MC, Claggett BL, Miao ZM, et al. Eur Heart J 2025;46:1321-1331.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ostrominski JW, Hojbjerg Lassen MC, Claggett BL, Miao ZM, et al. Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease. Eur Heart J 2025;46:1321-1331.
PMID: 39568016